How are we changing clinical trials?

How are we changing clinical trials?

How are we changing clinical trials?

Blog

AD/PD 2021: Unlearn will present novel, AI-driven approaches to enabling smaller, more efficient Alzheimer’s clinical trials

Join us at The 15th​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, March 9 - 14, 2021.
Blog

CTAD 2020: Unlearn will present abstracts to demonstrate how Digital Twins enable smaller, more efficient trials

Publications

Digital Control Subjects for Alzheimer's Disease Clinical Trials (AMIA 2019)

Blog

Reflections on AAIC 2019: Community, Cause, and Challenges

While treating the patient is the utmost priority, we need to understand that Alzheimer’s impacts every part of a person’s life and to address all of those parts, both effectively and compassionately.
The ability to simulate dozens of clinical characteristics simultaneously is a powerful tool to model disease progression.
Unlearn will present data from two separate abstracts demonstrating how Digital Twins can power novel trial designs and accelerate timelines.

Machine learning for comprehensive forecasting of Alzheimer's Disease progression

Blog

Digital Twins: A Tool for Risk Mitigation in the Era of COVID-19

In what ways can we mitigate risk and apply innovative solutions to unstable trials in the wake of COVID-19?
Blog

Learning from Data Across the Alzheimer's Disease Spectrum

No items found.
No items found.
No items found.
No items found.
At AAIC, I watched the talks with this question in mind: how would we build a model of disease progression in the early stages of AD?

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.